Avivagen Inc. ( VIVXF) - Stock Earnings
VIVXF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -860053 USD | 49220 USD |
| 2023Q1 | -911547 USD | 56884 USD |
| 2023Q2 | -703936 USD | 30578 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
VIVXF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | -3.6 million USD | 884210 USD |
| 2021 | -5.2 million USD | 1.0 million USD |
| 2022 | -4.5 million USD | 689887 USD |
| 2024 Est. | — | — |
VIVXF
Price: $0
52 week price:
Earnings Per Share: -0.04 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 12509